Limits...
Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages.

Dubey A, Park DW, Kwon JE, Jeong YJ, Kim T, Kim I, Kang SC, Chi KW - Int J Nanomedicine (2015)

Bottom Line: Compounds 9 and 10 showed potent antioxidant activity, but 10 had the superior ORACPE value (1.30 ± 0.020).In a tumoricidal assay, ellagic acid (5) and compound 10 induced cytotoxicity in tumor cells, while doxorubicin did not.While free ellagic acid had no effect on the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein, the encapsulated metalla-prism 10 stimulated granulocyte-colony stimulating factor and reduced regulated on activation normal T cell expressed and secreted protein expression in the RAW264.7 macrophage line.

View Article: PubMed Central - PubMed

Affiliation: Department of Chemistry, University of Ulsan, Ulsan, Republic of Korea.

ABSTRACT
Three new large hexanuclear metalla-prisms 9-11 incorporating 1,3, 5-tris(pyridin-4-ylethynyl)benzene (tpeb) 4 and one of the dinuclear arene ruthenium clips [Ru2(p-iPrC6H4Me)2(OO∩OO)][CF3SO3]2 (OO∩OO =2,5-dioxydo-1,4-benzoquinonato [dobq] 1, 5,8-dihydroxy-1,4-naphthaquinonato (donq) 2, and 6,11-dihydroxy-5,12-naphthacenedionato [dotq] 3), which encapsulate the guest molecule ellagic acid (2,3,7,8-tetrahydroxy-chromeno[5,4,3-cde]chromene-5,10-dione, 5) were prepared. All complexes were isolated as triflate salts in good yields and were fully characterized by (1)H NMR spectroscopy and electrospray ionization mass spectrometry. The photophysical properties of these metalla-prisms were also investigated. Compounds 9 and 10 showed potent antioxidant activity, but 10 had the superior ORACPE value (1.30 ± 0.020). Ellagic acid (5) and compound 11 showed weaker activity than that of Trolox. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the metalla-prism compounds exhibit anticancer properties in vitro. Compound 10 inhibited the growth of all cancer cell lines at micromolar concentrations, with the highest cytotoxicity observed against A549 human lung cancer cells (IC50 =25.9 μM). However, these compounds had a lower anti-cancer activity than that of doxorubicin. In a tumoricidal assay, ellagic acid (5) and compound 10 induced cytotoxicity in tumor cells, while doxorubicin did not. While free ellagic acid had no effect on the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein, the encapsulated metalla-prism 10 stimulated granulocyte-colony stimulating factor and reduced regulated on activation normal T cell expressed and secreted protein expression in the RAW264.7 macrophage line. Our results show that ellagic acid encapsulated in metalla-prisms inhibited cancer cells via the modulation of mRNA induction and protein expression levels of the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein in macrophages.

No MeSH data available.


Related in: MedlinePlus

(A) Synthesis of ellagic acid-encapsulated arene-ruthenium metalla-prisms 9–11 and (B) arene-ruthenium metalla-prisms 6–8.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4562765&req=5

f1-ijn-10-227: (A) Synthesis of ellagic acid-encapsulated arene-ruthenium metalla-prisms 9–11 and (B) arene-ruthenium metalla-prisms 6–8.

Mentions: Syntheses of the empty metalla-prisms 6, 7, and 8 have been reported previously.14 Ellagic acid (5) encapsulated in metalla-prisms 9, 10, and 11 were readily prepared quantitatively by the reaction of one of the binuclear [Ru2(p-iPrC6H4Me)2(dobq)(MeOH)2][CF3SO3]21,40 [Ru2(p-iPrC6H4Me)2(donq)(H2O)2][CF3SO3]22,41 or [Ru2(p-iPrC6H4Me)2(dotq)][CF3SO3]2314 acceptors with the tripyridyl donor 442 and ellagic acid (5) in a 3:2:1 ratio (Figure 1). The addition of diethyl ether to the concentrated reaction mixtures resulted in the isolation of analytically pure hexanuclear cages as crystalline solids. All the cages were fully characterized by 1H NMR, electrospray ionization mass spectrometry, and UV/Vis absorption.


Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages.

Dubey A, Park DW, Kwon JE, Jeong YJ, Kim T, Kim I, Kang SC, Chi KW - Int J Nanomedicine (2015)

(A) Synthesis of ellagic acid-encapsulated arene-ruthenium metalla-prisms 9–11 and (B) arene-ruthenium metalla-prisms 6–8.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4562765&req=5

f1-ijn-10-227: (A) Synthesis of ellagic acid-encapsulated arene-ruthenium metalla-prisms 9–11 and (B) arene-ruthenium metalla-prisms 6–8.
Mentions: Syntheses of the empty metalla-prisms 6, 7, and 8 have been reported previously.14 Ellagic acid (5) encapsulated in metalla-prisms 9, 10, and 11 were readily prepared quantitatively by the reaction of one of the binuclear [Ru2(p-iPrC6H4Me)2(dobq)(MeOH)2][CF3SO3]21,40 [Ru2(p-iPrC6H4Me)2(donq)(H2O)2][CF3SO3]22,41 or [Ru2(p-iPrC6H4Me)2(dotq)][CF3SO3]2314 acceptors with the tripyridyl donor 442 and ellagic acid (5) in a 3:2:1 ratio (Figure 1). The addition of diethyl ether to the concentrated reaction mixtures resulted in the isolation of analytically pure hexanuclear cages as crystalline solids. All the cages were fully characterized by 1H NMR, electrospray ionization mass spectrometry, and UV/Vis absorption.

Bottom Line: Compounds 9 and 10 showed potent antioxidant activity, but 10 had the superior ORACPE value (1.30 ± 0.020).In a tumoricidal assay, ellagic acid (5) and compound 10 induced cytotoxicity in tumor cells, while doxorubicin did not.While free ellagic acid had no effect on the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein, the encapsulated metalla-prism 10 stimulated granulocyte-colony stimulating factor and reduced regulated on activation normal T cell expressed and secreted protein expression in the RAW264.7 macrophage line.

View Article: PubMed Central - PubMed

Affiliation: Department of Chemistry, University of Ulsan, Ulsan, Republic of Korea.

ABSTRACT
Three new large hexanuclear metalla-prisms 9-11 incorporating 1,3, 5-tris(pyridin-4-ylethynyl)benzene (tpeb) 4 and one of the dinuclear arene ruthenium clips [Ru2(p-iPrC6H4Me)2(OO∩OO)][CF3SO3]2 (OO∩OO =2,5-dioxydo-1,4-benzoquinonato [dobq] 1, 5,8-dihydroxy-1,4-naphthaquinonato (donq) 2, and 6,11-dihydroxy-5,12-naphthacenedionato [dotq] 3), which encapsulate the guest molecule ellagic acid (2,3,7,8-tetrahydroxy-chromeno[5,4,3-cde]chromene-5,10-dione, 5) were prepared. All complexes were isolated as triflate salts in good yields and were fully characterized by (1)H NMR spectroscopy and electrospray ionization mass spectrometry. The photophysical properties of these metalla-prisms were also investigated. Compounds 9 and 10 showed potent antioxidant activity, but 10 had the superior ORACPE value (1.30 ± 0.020). Ellagic acid (5) and compound 11 showed weaker activity than that of Trolox. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the metalla-prism compounds exhibit anticancer properties in vitro. Compound 10 inhibited the growth of all cancer cell lines at micromolar concentrations, with the highest cytotoxicity observed against A549 human lung cancer cells (IC50 =25.9 μM). However, these compounds had a lower anti-cancer activity than that of doxorubicin. In a tumoricidal assay, ellagic acid (5) and compound 10 induced cytotoxicity in tumor cells, while doxorubicin did not. While free ellagic acid had no effect on the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein, the encapsulated metalla-prism 10 stimulated granulocyte-colony stimulating factor and reduced regulated on activation normal T cell expressed and secreted protein expression in the RAW264.7 macrophage line. Our results show that ellagic acid encapsulated in metalla-prisms inhibited cancer cells via the modulation of mRNA induction and protein expression levels of the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein in macrophages.

No MeSH data available.


Related in: MedlinePlus